Herpetic keratitis: etiology, pathogenesis, diagnosis, treatment

Authors

  • V. N. Sakovich Днепропетровская государственная медицинская академия, Днепропетровская областная клиническая офтальмологическая больница; Днепропетровск (Украина)
  • T. S. Nikitchina Днепропетровская государственная медицинская академия, Днепропетровская областная клиническая офтальмологическая больница; Днепропетровск (Украина)
  • B. D. Scherbakov Днепропетровская государственная медицинская академия, Днепропетровская областная клиническая офтальмологическая больница; Днепропетровск (Украина)

DOI:

https://doi.org/10.31288/oftalmolzh201457080

Abstract

Herpetic keratitis: etiology, pathogenesis, diagnosis, treatment

References

1. Анина Е. И., Мартопляс К. В. Патология роговой оболочки глаз среди взрослого населения Украины // XII з'ізд офтальмологів України, 26- 28 травня 2010р.: матеріали з'їзда. - Одеса, 2010. - С.5.

2. Амир Масуд. Диагностика и лечение герпетической рецидивирующей эрозии роговицы. Диссертация на соискание учёной степени кандидата медицинских наук, НИИ глазных болезней РАМН, 2009.

3. Аверьянова О. С, Ковалев А. И. Терапевтическая кератэктомия в лечении помутнений роговицы после герпетических кератитов: оптимизация параметров //Сучасні медичні технології № 2 (14), 2012. Медицин­ский центр АИЛАЗ, Киев, Украина.

4. Белозеров Е. С, Буланьков Ю. И. Болезни герпесвирусной группы. - Элиста : АПП «Джангар», 2005.

5. Вьючная М. Б. Дифференцированная иммунокоррекция в комплексном лечении герпетического кератита. - Дисс....... канд. мед. наук. - Воронежская гос.мед. академия Федерального агентства по здравоох­ранению и социальному развитию. - Воронеж, 2008.

6. Гулиева М. Г. Эффективность Офтальмоферона в комбинированном противовирусном лечении тяжелого стромального герпетического кератита // Реф­ракционная хирургия и офтальмология. - 2006. - Том 6. (№ 4).

7. Гайдамака Т. Б. Эффективность сквозной и послойной кератопластики при рецидиве герпетического ке­ратита // Офтальмол. журн. - 2007. - № 6.

8. Гайдамака Т. Б. Сравнение оптических результатов сквозной и послойной кератопластики, произведен­ной в стадии ремиссии у больных герпетическими ке­ратитами // Офтальмол. журн. - 2007. - № 5.

9. Жабоедов Г. Д., Витовская О. П. Глазные капли окоферон в лечении различных форм офтальмогерпеса // Здоров'я України, № 72, 2003г.

10. Исаков В. А., Рыбалкин С. Б., Романцов М. Г. Герпесвирусная инфекция. - Рекомендации для врачей. - Санкт-Петербург, 2006.

11. Ильина Е. Н. Аутолимбальная трансплантация в лечении стромальных метагерпетических кератитов, осложненных лимбальной недостаточностью // Харківська хірургічна школа № 5 (43), 2010.

12. Каспаров А. А. Современные методы лечения герпесвирусного кератита // Научно-практич. конф. «Со­временные методы диагностики и лечения заболева­ний роговицы и склеры». - Тезисы докл. - Москва,2007. - С.273- 276.

13. Каспаров А. А. Офтальмогерпес. - М.: Медицина, 1994. - 224 с.

14. Катаргина Л. А., Шестова Ю. П., Денисова Е. В. Состояние эндотелия роговицы при эндогенных увеи-тах у детей по данным конфокальной микроскопии // НИИ ГБ им. Гельмгольца МЗ России. - Москва,2012.

15. Майчук Н. Ф. Офтальмоферон. Опыт расширения области применения при глазных заболеваниях. - Мо­сква, 2012.

16. Маркелова Е. В., Дерибасова Н. Н. Патогенетическая роль дисфункций местного иммунитета при офталь-могерпесе // Герпес. (Приложение к «Российско­му журналу кожных и венерических болезней»). - 2008. - № 1. - С.6-8.

17. Майчук Ю. Ф., Селиверстова К. Е, Яни Я. В., Стирманова Е. Р. Оптическая когерентная томография переднего отдела глаза при герпетических пораже­ниях роговицы // Сб. трудов научно-практич. конф. по офтальмохирургии с междунар. участием. - Уфа,2011.

18. Пасечникова Н. В., Гайдамака Т. Б., Дрожжина Г. И., Драіомирецкая Е. И. Медицинская реабилитация больных герпетическими кератитами // Сучасні інфекції. - 2009. - № 2.

19. Рыков С. А., Знаменская М. А. Современные взгляды на этиологию и лечение герпетических кератитов // Новости медицины и фармации. - 2010.

20. Самгин М. А., Халдин А. А. Простой герпес (дер­матологические аспекты). - М.: МЕДпрессинформ,2002.

21. Сухина Л. А., Голубов К. Э., Смирнова А. Ф., Котлубей Г. В. Пути оптимизации терапии поверх­ностных форм герпетического поражения роговицы // Таврический медико-биологический вестник. - 2011. - Том 14, ч.2 (56).

22. Сухина Л. А., Голубов К. Э., Смирнова А. Ф., Котлубей Г. В. Особенности интерферонотерапии герпетических заболеваний роговицы // Таврический медио-биологический вестник. - 2011. - Том 14, № 4 ч.2 (56).

23. Ситник Г. В., Имшенецкая Т. А. Оптическая когерентная томография переднего отрезка глаза: учебно-метод. пособие. - Минск, 2009. - 32 с.

24. Третьякова Е. И., Гостева И. В. Лечение рецидивирующих инфекций, вызываемых вирусами про­стого герпеса // Альманах клин. медицины. - 2007. - № 15. - С.108-113.

25. Халдин А. А., Самгин М. А., Львов А. Н. Алоритм ведения больных рецидивирующим простым герпесом: от науки к практике // Приложение к «Росс. журналу кожных и венерических болезней» Герпес. - 2008. - № 1. - С.21-24.

26. Arvin A., Campadelli - Fiume G., Mocarski E., et al. Human Herpesviruses: Biology, Therapy, and Immuno-prophylaxis // Cambridge: Cambridge University Press; 2007. - Р. 656- 71.https://doi.org/10.1017/CBO9780511545313

27. Aim A., Grierson I., Shields M. B. Side effects associated with prostaglandin analog therapy // Survey of Ophthal­mology. - 2008. - Vol.53. - P. 93- 105.https://doi.org/10.1016/j.survophthal.2008.08.004

28. Aubert M., Krantz E. M., Jerome K. R. Herpes simplex virus genes Us3, Us5, and Us12 differentially regulate cy­totoxic T lymphocyte-induced cytotoxicity // Viral Im­munology. - 2006. - Vol.19. - P.391- 408.https://doi.org/10.1089/vim.2006.19.391

29. Andrei G., Snoeck R. Herpes simplex virus drug-resistance: new mutations and insights // Current Opinion in Infectious Diseases. - 2013. - Vol.26. - P.551- 60.https://doi.org/10.1097/QCO.0000000000000015

30. Bettahi I., Zhang X., Ann Re, Benmohamed L. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 im­mune response // Viral Immunol. - 2006. - Vol.19 (2). - Р. 220- 236.https://doi.org/10.1089/vim.2006.19.220

31. Bertke A. S., Apakupakul K., Ma A., Imai Y. et al. LAT region factors mediating differential neuronal tropism of HSV-1 and HSV-2 do not act in trans // PLoS One. - 2012. - 7 (12): e53281.https://doi.org/10.1371/journal.pone.0053281

32. Borkar D. S., Gonzales J. A., Tham V. M. et al. Association Between Atopy and Herpetic Eye Disease: Results From the Pacific Ocular Inflammation Study // JAMA Ophthal­mol. - 2014. - Vol.132. - P. 326- 31.https://doi.org/10.1001/jamaophthalmol.2013.6277

33. Belshe R. B., Leone P. A., Bernstein D. I. et al. Efficacy re­sults of a trial of a herpes simplex vaccine // The New Eng­land Journal of Medicine.- 2012.- Vol. 366.- P. 34- 43.https://doi.org/10.1056/NEJMoa1103151

34. Binnicker M. J., Jespersen D. J., Harring J. A. Evaluation of Three Multiplex Flow Immunoassays Compared to an Enzyme Immunoassay for the Detection and Differen­tiation of IgG Class Antibodies to Herpes Simplex Virus Types 1 and 2 // Clinical and vaccine Immunology. - 2010. - Vol.17. - P.253- 7.https://doi.org/10.1128/CVI.00325-09

35. Chentoufi A., Kritzer E., Tran M. et al. The herpes simplex virus 1 latency-associated transcript promotes functional exhaustion of virus-specific CD8+ T cells in latently in­fected trigeminal ganglia: a novel immune evasion mechanism // J. Virol.- 2011. - Vol. 85. - P. 9127- 9138.https://doi.org/10.1128/JVI.00587-11

36. Chentoufi A., Dervillez X., Dasgupta G. et al. The Herpes Simplex Virus Type 1 Latency Associated Transcript Inhibits Phenotypic and Functional Maturation of Dendritic Cells // Viral Immunology. - 2012. - Vol.25. - P.204- 215.https://doi.org/10.1089/vim.2011.0091

37. Chentoufi A., Kritzer E., Tran M. et al. The herpes simplex virus 1 latency-associated transcript promotes functional exhaustion of virus-specific CD8+ T cells in latently in­fected trigeminal ganglia: a novel immune evasion mecha­nism // J Virol.- 2011. - Vol.85. - P. 9127- 9138. A first demonstration of an immune evasion function of HSV-1 LAT gene.https://doi.org/10.1128/JVI.00587-11

38. Camarena V., Kobayashi M., Kim J. Y. et al. Nature and duration of growth factor signaling through receptor tyro-sine kinases regulates HSV-1 latency in neurons // Cell Host Microbe. - 2010. - Vol.8. - P. 320- 30.https://doi.org/10.1016/j.chom.2010.09.007

39. Chentoufi A., Kritzer E., Nesburn A., Benmohamed L. Towards a Rational Design of an Asymptomatic Clinical Herpes Vaccine: The Old, The New, and The Unknown // Clinical and Developmental Immunology. - 2012:187585. doi: 10.1155/2012/187585. Epub 2012 Mar 26. A first discovery of human symtomatic and asymptomatic epitopes in herpes glycoprotein B (gB).https://doi.org/10.1155/2012/187585

40. Colin J. Ganciclovir ophthalmic gel, 0.15 %: a valuable tool for treating ocular herpes // Clinical Ophthalmol­ogy. - 2007.-Vol.1. - P. 441- 53.

41. Dasgupta G., Ben Mohamed L. Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell - epitopes - based immunotherapeu-tic vaccine candidates? // Vaccine. - 2011. - Vol.29. - P.5824- 5836. An overview of how animal models are important in developing a therapeutic vaccine against herpes.https://doi.org/10.1016/j.vaccine.2011.06.083

42. Dean S. J., Novitskaya E. S., Moore T. C., Moore J. E.,Sharma A. Documentation of corneal epithelial defects with fluorescein-enchsnced digital fundus camera pho­tography // Clin. Experiment. Ophthalmol. - 2008. - Vol.36. - P.113-8.https://doi.org/10.1111/j.1442-9071.2008.01703.x

43. Duan R., de Vries R. D., Osterhaus A. D., Remeijer L., Verjans G. M. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis // J. Infect. Dis. - 2008. - Vol.198. - P.659- 63.https://doi.org/10.1086/590668

44. Dasgupta G., Chentoufi A. A., Nesburn A. B., Wechsler S. L., BenMohamed L. New concepts in herpes simplex virus vaccine development: notes from the battlefield // Expert Rev. Vaccines.- 2009. - Vol.8. - P.1023- 1035.https://doi.org/10.1586/erv.09.60

45. Dasgupta G., Chentoufi A., Kalantari-Dehaghi M., et al. Immunodominant «Asymptomatic» Herpes Sim­plex Virus Type 1 and Type 2 Protein Antigens Identi­fied by Probing Whole ORFome Microarrays By Serum Antibodies From Seropositive Asymptomatic Versus Symptomatic Individuals //J. Virology. - 2012. - Vol.86. - P.4358- 4369. A first genone-wide discovery of symptomatic and asymptomatic antigens from HSV-1 and HSV-2.https://doi.org/10.1128/JVI.07107-11

46. Egan K. P., Wu S., Wigdahl B., Jennings S. R. Immunological control of herpes simplex virus infections // Journal of Neurovirology. - 2013. - Vol.19. - P. 328- 45.https://doi.org/10.1007/s13365-013-0189-3

47. Farooq A. V., Shukla D. Herpes simplex epithelial and stro-mal keratitis: an epidemiologic update // Survey of oph­thalmology. - 2012. - Vol.57. - P.448- 62.https://doi.org/10.1016/j.survophthal.2012.01.005

48. Ferrari G., Iuliano L., ViganT M., Rama P. Impending corneal perforation after collagen cross-linking for herpetic keratitis // Journal of cataract and refractive surgery. - 2013. - Vol.39. - P. 638- 41.https://doi.org/10.1016/j.jcrs.2013.02.006

49. Gitman M. R., Ferguson D., Landry M. L. Comparison of Simplexa™ HSV 1 & 2 Direct PCR with Culture, Immu­nofluorescence and Laboratory Developed TaqMan PCR for Detection of Herpes Simplex Virus in Swab Specimens // Journal of clinical microbiology. - 2013. - Vol.51.-P. 3765- 3769.https://doi.org/10.1128/JCM.01413-13

50. Gabison E. E., Alfonsi N., Doan S., et al. Archipelago keratitis: a clinical variant of recurrent herpetic keratitis? // Ophthalmology. - 2007. - Vol.114. - P.2000- 5.https://doi.org/10.1016/j.ophtha.2007.01.004

51. Goldblum D., Bachmann C., Tappeiner C., Garweg J., Frueh B. E. Comparison of oral antiviral therapy with vala-cyclovir or acyclovir after penetrating keratoplasty for her-petic keratitis // Br. J. Ophthalmol. - 2008. - Vol. 92. - P. 1201-5.https://doi.org/10.1136/bjo.2008.138065

52. Garcia D. D., Shtein R. M., Musch D. C., Elner V. M. Herpes simplex virus keratitis: histopathologic neovasculariza­tion and corneal allograft failure // Cornea. - 2009. - Vol.28. - P.963- 965.https://doi.org/10.1097/ICO.0b013e31819c4e55

53. Hsiao C. H., Yeung L., Yeh L. K. el al. Pediatric herpes simplex virus keratitis // Cornea. - 28 (3). - 2009. - P.249- 53.https://doi.org/10.1097/ICO.0b013e3181839aee

54. Helena M. Herpes Simplex Virus Epithelial Keratitis. In Vivo Morphology in the Human Cornea // Springer Hei­delberg Dordrecht London New York, 2010.

55. Hashizume K., Nabeshima T., Fujiwara T., Machida S., Kurosaka D. A case of herpetic epithelial keratitis after triamcinolone acetonide subtenon injection // Cornea. - 2009. - Vol.28. - P.463-4.https://doi.org/10.1097/ICO.0b013e31818a7d9a

56. Hassan M., Patel D. K., Subrayan V. Primary herpes virus keratitis after penetrating keratoplasty // Annals of oph­thalmology (Skokie, Ill.). - 2009. - Vol.41. - P.203- 5.

57. Holland E. J., Schwartz G. S. Classification of herpes simplex virus keratitis // Cornea. - 1999. - Vol.18. - P.144-54.https://doi.org/10.1097/00003226-199903000-00002

58. Hayashi K., Hooper L. C., Shimomura Y. Who pays the toll for solving the enigma of corneal herpes? // Cornea. - 2013. - Vol.32. - P.3-12.https://doi.org/10.1097/ICO.0b013e3182a2dfc5

59. HlinomazovG Z., Sera O., Hor6ckov6 M. et al. Applying the DNA diagnostics in patients with superficial keratitis of viral origin // Cesk. Slov. Oftalmol. - 2008. - Vol.64. - P.47-51.

60. HJinomazova Z., Loukotova V., Horackova M., Sery O. The treatment of HSV1 ocular infections using quan­titative real-time PCR results// Acta Ophthalmologica. - 2012. - Vol.90. - P.456- 60.

https://doi.org/10.1111/j.1755-3768.2010.01933.x

61. Hafezi W., Eing B. R., Lorentzen E. U. et al. Reciprocal transmission of herpes simplex virus type 1 (HSV-1) be­tween corneal epithelium and trigeminal neurites in an embryonic chick organ culture// FASEB Journal: Fed­eration of American Societies for Experimental Biology. - 2002. - Vol.16. - P.878- 80.https://doi.org/10.1096/fj.01-0803fje

62. Hamrah P., Cruzat A., Dastjerdi M. H., et al. Corneal sen­sation and subbasal nerve alterations in patients with her­pes simplex keratitis: an in vivo confocal microscopy study // Ophthalmology. - 2010. - Vol.117. - P.1930- 6.https://doi.org/10.1016/j.ophtha.2010.07.010

63. Hamrah P., Cruzat A., Dastjerdi M. H. et al. Corneal sen­sation and subbasal nerve alterations in patients with her­pes simplex keratitis: an in vivo confocal microscopy study // Ophthalmology. - 2010. - Vol.117. - P.1930- 6.https://doi.org/10.1016/j.ophtha.2010.07.010

64. Hillenaar T., Weenen C., Wubbels R. J., Remeijer L. En-dothelial involvement in herpes simplex virus keratitis: an in vivo confocal microscopy study // Ophthalmology. - 2009. - Vol.116. - P.2077-86.https://doi.org/10.1016/j.ophtha.2009.04.022

65. Hill J. M., Clement C. Herpes simplex virus type 1 DNA in human corneas: what are the virological and clinical im­plications? // J. Infect Dis. - 2009. - Vol.200. - P.1-4.https://doi.org/10.1086/599330

66. Jones R., Pasquale L. R., Pavan-Langston D. Herpes simplex virus: an important etiology for secondary glau­coma // Int. Ophthalmol. Clin. - 2007. - Vol.47. - P.99-107.https://doi.org/10.1097/IIO.0b013e3180377632

67. Jain V., Pineda R. Reactivated herpetic keratitis following laser in situ keratomileusis // Journal of cataract and re­fractive surgery. - 2009. - Vol.35. - P.946- 8.https://doi.org/10.1016/j.jcrs.2008.11.065

68. Kaye S., Choudhary A. Herpes simplex keratitis // Prog. Retin. Eye Res. - 2006. - Vol.25. - P.355- 80.https://doi.org/10.1016/j.preteyeres.2006.05.001

69. Kim J. Y., Mandarino A., Chao M. V., Mohr I., Wlson A. C. Transient reversal of episome silencing precedes VP16-dependent transcription during reactivation of latent HSV-1 in neurons // PLoS Pathog. - 2012. - Vol.8 (2) : e1002540.https://doi.org/10.1371/journal.ppat.1002540

70. Khalid F. Tabbara, Noorjehan Al. Balushi. Topical ganciclovir in the treatment of acute herpetic keratitis // Clini­cal Ophthalmology. - 2010. - Vol.4. - P.905- 912. Published online 2010 August 19. PMCID: PMC2925452.https://doi.org/10.2147/OPTH.S8666

71. Khalili M. R., Mehdizadeh M., Mehryar M. Herpetic epithelial keratitis after intravitreal injection of bevacizumab (Avastin) // Cornea. - 2009. - Vol.28. - P.360- 1.https://doi.org/10.1097/ICO.0b013e318189137a

72. Kymionis G. D., Portaliou D. M., Bouzoukis D. I. et al. Herpetic keratitis with iritis after corneal crosslinking with riboflavin and ultraviolet A for keratoconus // Journal of Cataract and Refractive Surgery. - 2007. - Vol.33. - P.1982- 4.https://doi.org/10.1016/j.jcrs.2007.06.036

73. Kalantari-Dehaghi M., Chun S., Chentoufi A., et al. Discovery of potential diagnostic and vaccine antigens in herpes simplex virus-1 and - 2 by proteome-wide antibody profiling // J. Virology. - 2012. - Vol.86. - P.4328- 39.https://doi.org/10.1128/JVI.05194-11

74. Konstantopoulos A., Hossain P., Anderson D. F. Recent advances in ophthalmic anterior segment imaging: a new era for ophthalmic diagnosis? // The British journal of ophthalmology. - 2007. - Vol.91. - P.551-7.https://doi.org/10.1136/bjo.2006.103408

75. Kaufman H. E., Haw W. H. Ganciclovir ophthalmic gel 0.15 %: safety and efficacy of a new treatment for herpes simplex keratitis // Current Eye Research. - 2012. - Vol.37. - P.654- 60.https://doi.org/10.3109/02713683.2012.692846

76. Kamimura A., Takata M. I., Fernandes A. C. et. al. Molecular detection of herpes simplex virus by polymerase chain reaction in patients with typical and atypical herpetic ker-atitis // Arquivos brasileiros de oftalmologia. - 2008. - Vol.71. - P.827- 30.

77. Labetoulle M., Colin J. Current concepts in the treatment of herpetic keratitis // Journal francais d'ophthalmologie.-2012. - Vol.35 (4). - Р.292- 307.https://doi.org/10.1016/j.jfo.2011.10.002

78. Lin T., Gong L., Sun X. H. et al. Effectiveness and safety of 0.15 % ganciclovir in situ ophthalmic gel for herpes simplex keratitis - a multicenter, randomized, investigator-masked, parallel group study in Chinese patients // Drug Design, development and therapy. - 2013. - Vol. 29. - P.357- 361.https://doi.org/10.2147/DDDT.S42624

79. Labetoulle M., Colin J. Current concepts in the treatment of herpetic keratitis // Journal francais d'ophtalmologie. - 2012. - Vol.35.- P. 292- 307.https://doi.org/10.1016/j.jfo.2011.10.002

80. Leigh J. F., Acharya N., Cevallos V., Margolis T. P. Does asymptomatic shedding of herpes simplex virus on the ocu­lar surface lead to false-positive diagnostic PCR results // British Journal of Ophthalmology. - 2008. - Vol.92. - P.435- 6.https://doi.org/10.1136/bjo.2007.122150

81. Lyall D. A., Tarafdar S., Gilhooly M. J. et al. Long term vi­sual outcomes, graft survival and complications of deep an­terior lamellar keratoplasty in patients with herpes simplex related corneal scarring // The British Journal of Ophthalmology. - 2012. - Vol.96. - P.1200- 3.https://doi.org/10.1136/bjophthalmol-2012-301947

82. Mucci J. J., Utz V. M., Galor A. et al. Recurrence rates of herpes simplex virus keratitis in contact lens and non­contact lens wearers // Eye and Contact Lens. - 2009. - Vol.35. - P. 185-7.https://doi.org/10.1097/ICL.0b013e3181a9d788

83. Martone G., Alegente M., Balestrazzi A. et al. In vivo con-focal microscopy in bilateral herpetic keratitis: a case re­port // Eur. J. Ophthalmol. - 2008. - Vol.18.- P.994-7.https://doi.org/10.1177/112067210801800622

84. Morishige N., Takahashi N., Chikamoto N., Nishida T. Quantitative evaluation of corneal epithelial oedema by confocal microscopy // Clinical & experimental ophthal­mology. - 2009. - Vol.37.- P.249-53.https://doi.org/10.1111/j.1442-9071.2009.02020.x

85. Miserocchi E., Modorati G., Galli L., Rama P. Efficacy of valacyclovir vs acyclovir for the prevention of recur­rent herpes simplex virus eye disease: a pilot study // Am. J. Ophthalmol. - 2007. - Vol.144. - P.547- 51.https://doi.org/10.1016/j.ajo.2007.06.001

86. Meller D., Thomasen H., Steuhl K. Amniotic membrane transplantation in herpetic corneal infections // Klinische Monatsblatter fur Augenheilkunde. - 2010. - Vol.227. - P.393-9.https://doi.org/10.1055/s-0029-1245339

87. Makdoumi K., Mortensen J., Crafoord S. Infectious keratitis treated with corneal crosslinking // Cornea. - 2010. - Vol.29. - P.1353- 8.https://doi.org/10.1097/ICO.0b013e3181d2de91

88. Morttn H., Malmsjn M., Mortensen J., Ohrstnnn A. Riboflavin and ultraviolet a collagen crosslinking of the cor­nea for the treatment of keratitis // Cornea. - 2010. - Vol.29. - P. 102-4.https://doi.org/10.1097/ICO.0b013e31819c4e43

89. Nesburn Ab., Bettahi I., Zhang X. et al. Topical mucosal delivery of sub-unit vaccines that stimulate the ocular mucosal immune system // Ocul. Surf. - 2006. - № 4.- P.178-187.https://doi.org/10.1016/S1542-0124(12)70164-7

90. Nishida T., Yanai R. Advances in treatment for neurotrophic keratopathy // Curr. Opin. Ophthalmol. - 2009. - Vol.20. - P. 276- 81.https://doi.org/10.1097/ICU.0b013e32832b758f

91. Nishida T., Yanai R. Advances in treatment for neurotrophic keratopathy // Curr. Opin. Ophthalmol.- 2009. - Vol.4. - P.276-81.https://doi.org/10.1097/ICU.0b013e32832b758f

92. Otri A. M., Fares U., Al-Aqaba M. A., Dua H. S. Corneal dencitometry as an indicator of corneal health // Ophthalmology. - 2012. - Vol.119. - P.501-8.https://doi.org/10.1016/j.ophtha.2011.08.024

93. Peri P., Nuutila K., Vuorinen T., Saukko P., Hukkanen V. Cathepsins are involved in virus-induced cell death in ICP4 and Us3 deletion mutant herpes simplex virus type 1-infected monocytic cells // The Journal of General Virology. - 2011. - Vol.92. - P.173- 80.https://doi.org/10.1099/vir.0.025080-0

94. Patel D. V., McGhee C. N. Laser scanning in vivo confocal microscopy demonstrating significant alteration of human corneal nerves following herpes zoster ophthalmicus // Arch. Neurol. - 2010. - Vol.67. - P.640-1.https://doi.org/10.1001/archneurol.2010.62

95. Patel D. V., McGhee C. N. In vivo confocal microscopy of human corneal nerves in health, in ocular and systemic disease, and following corneal surgery: a review // Br.J. Ophthalmol. - 2009. - Vol.93. - P.853-60.https://doi.org/10.1136/bjo.2008.150615

96. Panda A., Vanathi M., Kumar A., Dash Y., Priya S. Corneal graft rejection // Surv. Ophthalmol. - 2007. - Vol.52. - P.375-96.https://doi.org/10.1016/j.survophthal.2007.04.008

97. Rowe A. M., St. Leger A. J., Jeon S. et al. Herpes keratitis // Progress in retinal & eye research.- 2013. - Vol. 13. - P.88-101.https://doi.org/10.1016/j.preteyeres.2012.08.002

98. Rhoda Ashley Morrow, David Friedrich, Amalia Meier, Lawrence Corey. Use of «biokit HSV-2 Rapid Assay» to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA // BMC Infectious Diseases. - 2007. - Vol.14. - P.5-84.

99. Remeijer L., Duan R., Dun J., Bettink M. Prevalence and clinical consequences of herpes simplex type 1 DNA in human cornea tissue // J. Infect. Dis. - 2009. - P.9-11.https://doi.org/10.1086/599329

100. Reinhart W. J., Musch D. C., Jacobs D. S. et la. Deep anterior lamellar keratoplasty as an alternative to penetrating keratoplasty a report by the american academy of ophthalmology // Ophthalmology. - 2011. - Vol.118. - P.209-18.https://doi.org/10.1016/j.ophtha.2010.11.002

101. Seitz B., Heiligenhaus A. « Herpetic keratitis ». Various expressions require different therapeutic approaches // Ophthalmologe. - 2011.-Vol. 108 (4). - P.385- 95.https://doi.org/10.1007/s00347-011-2346-5

102. Smith G. Review Herpesvirus transport to the ner­vous system and back again // Annu Rev. Microbiol. - 2012. - Vol.66. - P.153-76.https://doi.org/10.1146/annurev-micro-092611-150051

103. Sacchetti M., Lambiase A. Diagnosis and management of neurotrophic keratitis // Clin. Ophthalmol. - 2014.- Vol.8. - P.571-9.https://doi.org/10.2147/OPTH.S45921

104. Shimomura Y. Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis // Nihon Ganka Gakkai Zasshi. - 2008. - Vol.112. - P.247- 64.

105. Sciortino M. T., Medici M. A., Marino-Merlo F. et al. Involvement of gD/HVEM interaction in NF-kB-de-pendent inhibition of apoptosis by HSV-1 gD // Bio­chemical Pharmacology. - 2008. - Vol.76. - P.1522- 32.https://doi.org/10.1016/j.bcp.2008.07.030

106. Shieh Y. Y., Perng G. C. Evaluation of severity of HSV-1 corneal infection by statistical pattern classification technique // Current eye research. - 2008. - Vol.33. - P.225-35.https://doi.org/10.1080/02713680801895460

107. Toma H. S., Murina A. T., Areaux R. G. et al. Ocu­lar HSV-1 latency, reactivation and recurrent disease // Seminars in Ophthalmology. - 2008. - Vol.23. - P.249-73.https://doi.org/10.1080/08820530802111085

108. Thompson R. L., Sawtell N. M. The herpes simplex virus type 1 latency associated transcript locus is required for the maintenance of reactivation competent latent infec­tions // J. Neurovirol. - 2011. - Vol.17. - P.552-8.https://doi.org/10.1007/s13365-011-0071-0

109. Thomson D. A., Tee E. H., Tran N. T., Monteiro M. J., Cooper M. A. Oligonucleotide and polymer function-alized nanoparticles for amplification-free detection of DNA // Biomacromolecules. - 2012. - Vol.13. - P.1981-9.https://doi.org/10.1021/bm300717f

110. Tayapad J. B., Viguilla A. Q., Reyes J. M. Collagen cross-linking and corneal infections // Curr. Opin. Ophthal-mol. - 2013. - Vol.24. - P.288- 90.https://doi.org/10.1097/ICU.0b013e32836229c5

111. Villegas V. M., Diaz L., Izquierdo N. J. Herpetic keratitis in a patient who used two different prostaglandin ana­logue ophthalmic solutions: a case report // Puerto Rico Health Sciences Journal. - 2008. - Vol.27. - P.348- 9.

112. Vadlapudi A. D., Vadlapatla R. K., Mitra A. K. Update on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective // Recent Pat. Antiinfect. Drug Discov. - 2013. - Vol.8. - P.55- 67.https://doi.org/10.2174/157489113805290755

113. van Velzen M., van de Vijver D. A., van Loenen F. B. et al. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis // The Journal of Infectious Diseases. - 2013. - Vol. 208. - P.1359- 65.https://doi.org/10.1093/infdis/jit350

114. Vasseneix C., Toubeau D., Brasseur G., Muraine M. Surgical management of nontraumatic corneal perforations: an 8-year retrospective study // Journal francais d' oph­talmologie. - 2006. - Vol.29. - P.751-62.https://doi.org/10.1016/S0181-5512(06)73844-X

115. Wilhelmus K. R. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial kera-titis // Cochrane Database Syst. Rev. - 2010.https://doi.org/10.1002/14651858.CD002898.pub4

116. Wang J., Zhao G., Xie L., Chen M., Zhao J. Therapeutic effect of deep anterior lamellar keratoplasty for active or quiescent herpetic stromal keratitis // Graefe's Ar­chive for Clinical and Experimental Ophthalmology. - 2012. - Vol. 250. - P.1187- 94.https://doi.org/10.1007/s00417-012-1947-2

117. Xu F., Sternberg M. R., Kottiri B. J. et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States // JAMA. - 2006. - Vol.296. - P.964- 973.https://doi.org/10.1001/jama.296.8.964

118. Xavier Dervillez, Chetan Gottimukkala, Khaled W. Kabbara et al. Future of an «Asymptomatic» T-cell Epitope-Based Therapeutic Herpes Simplex Vaccine // Future Virol. - 2012. - Vol.7. - P.371- 378.https://doi.org/10.2217/fvl.12.22

119. Xiang Z., He Y. Genome-wide prediction of vaccine targets for human herpes simplex viruses using Vaxign reverse vaccinology // BMC Bioinformatics. - 2013. - Vol.14. - P.2.https://doi.org/10.1186/1471-2105-14-S4-S2

120. Young R. C., Hodge D. O., Liesegang T. J., Baratz K. H. Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976-2007: the effect of oral antiviral pro­phylaxis // Arch Ophthalmol. - 2010. - Vol.128. - P. 1178-83.https://doi.org/10.1001/archophthalmol.2010.187

Published

2014-10-30

Issue

No. 5 (2014): Journal of Ophthalmology (Ukraine)

Section

Literature Review

License

Copyright (c) 2014 В. Н. Сакович, Т. С. Никитчина, Б. Д. Щербаков

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.

COPYRIGHT NOTICE

Authors who publish in this journal agree to the following terms:

  1. Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
  2. The copyright commencement date complies the publication date of the issue, where the article is included in.

DEPOSIT POLICY

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
  3. Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
  4. Archiving the pre-print (pre-refereeing manuscript version) not allowed.